Daniel J Starks has bought ABT on 2 days since Feb 2026

Daniel J. Starks is a seasoned healthcare executive serving as an Independent Director on the Board of Directors of Abbott Laboratories (ABT) since February 15, 2017.( He recently engaged in insider trading activities at Abbott Laboratories as a Director.(

Starks had a distinguished career at St. Jude Medical, Inc., joining in 1996 and rising to Chairman, President, and Chief Executive Officer from 2004 until his retirement in January 2016, followed by serving as Executive Chairman until Abbott's acquisition of the company in January 2017.( Earlier roles included President and Chief Operating Officer (2001-2004) and President and CEO of the Cardiac Rhythm Management Business (1997-2001).( He previously led companies such as Daig Corp. (acquired by St. Jude in 1996), Advanced Neuromodulation Systems, Inc., Epicor Medical, Inc., and Cardiac Rhythm Management as President and CEO.( Starks brings extensive expertise in the medical device industry and global public company management to Abbott's board.( His ownership includes over 6.7 million ABT shares, contributing to an estimated net worth exceeding $700 million.(

Written by Perplexity from public sources.